since the myopathic changes observed in this study were produced by neostigmine , a drug which is commonly employed in the routine treatment of human patients with myasthenia gravis , continued use of neostigmine for long-term therapy in noncrisis situations may not be accepted as being free from risk .
C0026896
myasthenia gravis
C0027679
neostigmine